The ’G’ represents the highly expressed glucose transporters Glut1 and Glut3 in lung adenocarcinomas. Left: the dual deletion impairing lung tumor growth. Credit: Liloon (Julie de Meyer)
The 'G' represents the highly expressed glucose transporters Glut1 and Glut3 in lung adenocarcinomas. Left: the dual deletion impairing lung tumor growth. Credit: Liloon (Julie de Meyer) - Treatments that block two sugar-transporting proteins could help slow the growth of lung tumours, new research from EPFL suggests. Blocking a pair of sugar-transporting proteins may be a useful treatment approach for lung cancer, suggests a new study in mice and human cells published today in eLife . Cancer cells use a lot of sugar to fuel their rapid growth and spread. This has led scientists to consider cutting off their sugar supply as a way to treat cancer. The current study suggests this could be an effective approach but it will be necessary to block multiple pathways at once to be effective.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
